CIK: 0001609251 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 13, 2021
Total Value ($000): $294,544 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS | 82,104 | $45,858 | 15.6% | $342.96 | +46.9% | COM | 75886F107 |
| ALKS | ALKERMES PLC | 1,688,841 | $41,410 | 14.1% | $18.73 | +18.7% | COM | G01767105 |
| ENTA | ENANTA PHARMACEUTICALS INC | 939,650 | $41,354 | 14.0% | $44.67 | +9.6% | COM | 29251M106 |
| UTHR | UNITED THERAPEUTICS CORP | 219,690 | $39,415 | 13.4% | $121.76 | +56.4% | COM | 91307C102 |
| — | TARO PHARMACEUTICAL INDUS | 543,705 | $39,125 | 13.3% | $78.11 | — | COM | M8737E108 |
| BIIB | BIOGEN INC | 97,523 | $33,769 | 11.5% | $311.05 | -2.6% | COM | 09062X103 |
| MCK | MCKESSON CORP | 166,436 | $31,829 | 10.8% | $138.18 | +36.1% | COM | 58155Q103 |
| — | SURGALIGN HOLDINGS INC | 6,403,077 | $8,900 | 3.0% | $1.82 | — | COM | 86882C105 |
| — | INVACARE CORP | 901,712 | $7,277 | 2.5% | $11.95 | — | COM | 461203101 |
| EGRX | EAGLE PHARMACEUTICALS INC | 70,804 | $3,030 | 1.0% | $41.26 | 0.0% | COM | 269796108 |
| TVTX | TRAVERE THERAPEUTICS INC | 140,000 | $2,043 | 0.7% | $19.72 | 0.0% | COM | 89422G107 |
| ANAB | ANAPTYSBIO INC | 10,890 | $282 | 0.1% | $23.65 | +1.4% | COM | 032724106 |
| — | NEXTCURE INC | 31,355 | $252 | 0.1% | $9.95 | — | COM | 65343E108 |